This is a competitive renewal of NIH T32 HL-07910 entitled: Basic Science Studies on Gene Therapy of Blood Diseases which is currently in its 15th year of funding. The discipline of gene therapy has had its ups and downs, but to continue to advance the field, we must train the next generation of investigators in this area.
The aim of this program is to continue to train this next generation of scientists in the clinically-relevant medical area of gene transfer for effective modulation of normal and abnormal cell growth and for gene therapy to correct blood diseases. We request 4 pre- and 5 post-doctoral slots, an increase of 1 pre-doc slot. We have an outstanding group of 23 very productive, interactive, and well-respected investigators as mentors with their primary and/or secondary faculty appointments in 8 departments of the medical school. These mentors have over their career trained a total of 169 pre-doctoral PhD and 284 post-doctoral students. Since the competitive renewal of this program in 2009, we were able to train and/or are in the process of training 11 pre- and 13 post-doctoral students, who have published 112 papers [37 (Pre-Doc) and 75 (Post-Doc)]. The Program Director (PD) has trained 17 pre-doctoral and 55 post- doctoral/clinical fellows, has published over 720 papers and been continuously funded by the NIH since 1978. He is a recognized authority on hematopoietic stem and progenitor cells, the regulation of hematopoiesis, and has had his work translated into clinical utility. The Co-PD, is also a well-recognized and well-funded productive investigator who has trained numerous students and fellows, and has had his work translated for clinical benefit. The PD and Co-PD have extensive administrative experience and have worked for many years in the area of gene transfer in efforts to enhance approaches to gene therapy. The vast majority of our trainees, since initial funding of this grant in 1999, have gone on to careers in academia and other research intensive areas of employment. Training of our pre- and post-doctoral students entails one-on-one interactions, committee and group mentorship, lab meetings, special seminars in the area of this training program, didactic courses, ethical training, presentations at scientific meetings and high expectations for the trainees to publish in respected scientific and medical journals, and to continue in their career development leading them to become productive independent investigators whose work will benefit healthcare in general and gene transfer/gene therapy in specific. Our training efforts are monitored and enhanced by both internal and external advisory committees.

Public Health Relevance

Understanding the basic biology of viral vectors and how best to transduce stem cells and keep these cells in efficient gene-expressing and engrafting form is crucial to the future successes of gene therapy. This training will provide the next generation of scientists in this exciting, but still not fully-realized translational and clinical, discipline of gene regulation and therapy for the health benefit of our citizens.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Sisti, Flavia; Wang, Soujuan; Brandt, Stephanie L et al. (2018) Nuclear PTEN enhances the maturation of a microRNA regulon to limit MyD88-dependent susceptibility to sepsis. Sci Signal 11:
Varberg, Kaela M; Winfree, Seth; Dunn, Kenneth W et al. (2018) Kinetic Analysis of Vasculogenesis Quantifies Dynamics of Vasculogenesis and Angiogenesis In Vitro. J Vis Exp :
Deng, Lisa; Richine, Briana M; Virts, Elizabeth L et al. (2018) Rapid development of myeloproliferative neoplasm in mice with Ptpn11 D61Y mutation and haploinsufficient for Dnmt3a. Oncotarget 9:6055-6061
Walline, Crystal C; Blum, Janice S; Linton, Tobyn et al. (2018) Early activation of peripheral monocytes with hallmarks of M1 and M2 monocytic cells in excessive alcohol drinkers: a pilot study. J Investig Med 66:1-4
Cai, Zhigang; Kotzin, Jonathan J; Ramdas, Baskar et al. (2018) Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis. Cell Stem Cell 23:833-849.e5
Patterson, Andrea M; Pelus, Louis M (2018) Spotlight on Glycolysis: A New Target for Cord Blood Expansion. Cell Stem Cell 22:792-793
Ren, Hong-Gang; Adom, Djamilatou; Paczesny, Sophie (2018) The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease. Expert Rev Clin Immunol 14:389-404
Patterson, Andrea M; Pelus, Louis M (2017) G-CSF in stem cell mobilization: new insights, new questions. Ann Blood 2:
Pham, Duy (2017) A Method to In Vitro Differentiate Th9 Cells from Mouse Naïve CD4+ T Cells. Methods Mol Biol 1585:51-57
Ramadan, Abdulraouf; Griesenauer, Brad; Adom, Djamilatou et al. (2017) Specifically differentiated T cell subset promotes tumor immunity over fatal immunity. J Exp Med 214:3577-3596

Showing the most recent 10 out of 114 publications